Sakar Healthcare Share Price

    NSE
    350.3
    -1.35 (0.29%)
    SAKAR • 02 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    7.13%

    3Y Annualised Return

    29.24%

    5Y Annualised Return

    40.64%

    The current prices are delayed, login or Open Demat Account for live prices.

    Sakar Healthcare Stock Performance

    1W Return-4.52
    1Y Return7.13
    Today's Low335
    Prev. Close351.65
    Mkt Cap (Cr.)767.04
    1M Return8.69
    3Y Return120.26
    52-Week High380.8
    Open351.65
    PE Ratio43.74
    6M Return15.29
    Today's High354
    52-Week Low210.1
    Face Value10

    Sakar Healthcare Company background

    Founded in: 2004
    Managing director: Sanjay S Shah.
    Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, antiemetics, antihistamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHOGMP, CGMP National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started commercial production for Plant 1 which was established for production of Liquid Orals in 2007, it started exporting its products overseas started commercial production for Plant 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup Blactum. / Sachet in 2008. Further, it started commercial production for Plant 3 which was established for production of Liquid Injectibles (SVP) Ampoules and Liquid Injectibles (SVP) Vials.In 2012, it started commercial production for Plant 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 202223, the Company started commercialization with Oncology product post receiving WHO GMP certification.

    As of 02 Jul, 2025, Sakar Healthcare share price is ₹349.4. The stock opened at ₹351.6 and had closed at ₹351.6 the previous day. During today’s trading session, Sakar Healthcare share price moved between ₹335.00 and ₹354.00, with an average price for the day of ₹344.50. Over the last 52 weeks, the stock has recorded a low of ₹210.10 and a high of ₹380.80. In terms of performance, Sakar Healthcare share price has increased by 15.9% over the past six months and has increased by 7.13% over the last year.

    Read More
    Sakar Healthcare SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹67,38,222 (+3.66%)

    Daily SIP of 25,000 would have become 67,38,222 in 1 year with a gain of 2,38,222 (+3.66%)

    View details of Market Depth

    Sakar Healthcare Fundamental

    Market Cap (in crs)

    767.04

    Face Value

    10

    Turnover (in lacs)

    47.81

    Key Metrics

    Qtr Change %
    66.33% Gain from 52W Low
    48.8
    Dividend yield 1yr %
    0

    Sakar Healthcare Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Sakar Healthcare Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    50.24 Cr
    43.42 Cr
    42.78 Cr
    41.15 Cr
    43.06 Cr
    Sakar Healthcare Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    178.9 Cr
    156.53 Cr
    138.03 Cr
    130.4 Cr
    95.91 Cr
    85 Cr
    Sakar Healthcare Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    5.76 Cr
    4.53 Cr
    4.8 Cr
    2.41 Cr
    3.12 Cr
    Sakar Healthcare Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    17.5 Cr
    11.67 Cr
    12.76 Cr
    15.18 Cr
    10.68 Cr
    9.62 Cr

    Sakar Healthcare Result Highlights

    • Sakar Healthcare Ltd reported a 0.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 3.2%.

    • Its expenses for the quarter were up by 2.2% QoQ and 1.2% YoY.

    • The net profit decreased 31.1% QoQ and decreased 20.4% YoY.

    • The earnings per share (EPS) of Sakar Healthcare Ltd stood at 1.4 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Sakar Healthcare

    Promoter
    53.6%
    Foreign Institutions
    13.6%
    Domestic Institutions
    11%
    Public
    21.8%
    Promoter
    53.6%
    Foreign Institutions
    13.6%
    Domestic Institutions
    10.8%
    Public
    22%
    Promoter
    53.2%
    Foreign Institutions
    13.4%
    Domestic Institutions
    10.6%
    Public
    22.8%
    Promoter
    53.2%
    Foreign Institutions
    13.5%
    Domestic Institutions
    10.6%
    Public
    22.7%
    Promoter
    53.2%
    Foreign Institutions
    13.5%
    Domestic Institutions
    10.6%
    Public
    22.7%
    Promoter
    53.2%
    Foreign Institutions
    13.8%
    Domestic Institutions
    10.6%
    Public
    22.5%

    Sakar Healthcare Technical Analysis

    Moving Averages Analysis
    350.3
    Current Price
    Bullish Moving Averages
    11
    Bearish Moving Averages
    5
    5Day EMA
    353.70
    10Day EMA
    351.90
    12Day EMA
    350.20
    20Day EMA
    342.80
    26Day EMA
    337.40
    50Day EMA
    320.20
    100Day EMA
    304.10
    200Day EMA
    301.90
    5Day SMA
    356.40
    10Day SMA
    357.20
    20Day SMA
    339.60
    30Day SMA
    331.50
    50Day SMA
    317.00
    100Day SMA
    283.20
    150Day SMA
    288.90
    200Day SMA
    295.20
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    13682 Rs
    13682 Rs
    Week Rs
    20364 Rs
    23370 Rs
    Month Rs
    23634 Rs
    51472 Rs
    346.15
    Pivot
    Resistance
    First Resistance
    357.30
    Second Resistance
    365.15
    Third Resistance
    376.30
    Support
    First Support
    338.30
    Second support
    327.15
    Third Support
    319.30
    Relative Strength Index
    59.07
    Money Flow Index
    80.95
    MACD
    12.79
    MACD Signal
    13.42
    Average True Range
    18.20
    Average Directional Index
    42.54
    Rate of Change (21)
    8.69
    Rate of Change (125)
    17.88
    Name
    Holding Percent
    Hbm Healthcare Investments (Cayman) Ltd
    6.83
    Cobra India (Mauritius) Limited
    6.46
    Tata Capital Healthcare Fund II
    10.52

    Sakar Healthcare Share Price FAQs

    Sakar Healthcare share price in the past 1-year return was 7.12. The Sakar Healthcare share hit a 1-year low of Rs. 210.1 and a 1-year high of Rs. 380.8.

    The market cap of Sakar Healthcare is Rs. 767.04 Cr. as of 2/7/2025.

    The PE ratios of Sakar Healthcare is 43.74 as of 2/7/2025.

    The PB ratios of Sakar Healthcare is 2.68 as of 2/7/2025

    You can easily buy Sakar Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Sakar Healthcare share price is ₹380.8 and ₹210.1 as of 2/7/2025.

    Please be aware that Sakar Healthcare stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    64.79
    -2.41 (-3.59%)
    140.31
    -1.19 (-0.84%)
    688.55
    +4.75 (+0.69%)
    2,630.20
    +8.40 (+0.32%)
    168.23
    -2.16 (-1.27%)
    392.65
    -3.20 (-0.81%)
    165.88
    +5.82 (+3.64%)
    259.75
    -1.25 (-0.48%)
    426.95
    -5.30 (-1.23%)
    406.65
    +0.10 (+0.02%)
    Top Gainers
    165.88
    +5.82 (+3.64%)
    1,059.90
    +30.30 (+2.94%)
    2,419.40
    +49.90 (+2.11%)
    12,436.00
    +226.00 (+1.85%)
    12,622.00
    +180.00 (+1.45%)
    Top Losers
    676.90
    -19.55 (-2.81%)
    789.70
    -20.20 (-2.49%)
    857.65
    -21.45 (-2.44%)
    2,007.90
    -45.90 (-2.23%)
    3,596.80
    -69.90 (-1.91%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -